Show simple item record

RYR1 mutations are a common cause of congenital myopathies with central nuclei

dc.contributor.authorWilmshurst, J. M.en_US
dc.contributor.authorLillis, S.en_US
dc.contributor.authorZhou, H.en_US
dc.contributor.authorPillay, K.en_US
dc.contributor.authorHenderson, H.en_US
dc.contributor.authorKress, W.en_US
dc.contributor.authorMüller, C. R.en_US
dc.contributor.authorNdondo, A.en_US
dc.contributor.authorCloke, V.en_US
dc.contributor.authorCullup, T.en_US
dc.contributor.authorBertini, E.en_US
dc.contributor.authorBoennemann, C.en_US
dc.contributor.authorStraub, V.en_US
dc.contributor.authorQuinlivan, R.en_US
dc.contributor.authorDowling, James J.en_US
dc.contributor.authorSarraj, S.en_US
dc.contributor.authorTreves, S.en_US
dc.contributor.authorAbbs, S.en_US
dc.contributor.authorManzur, A. Y.en_US
dc.contributor.authorSewry, C. A.en_US
dc.contributor.authorMuntoni, F.en_US
dc.contributor.authorJungbluth, H.en_US
dc.date.accessioned2010-11-03T15:21:16Z
dc.date.available2011-03-01T16:26:48Zen_US
dc.date.issued2010-11en_US
dc.identifier.citationWilmshurst, J.M.; Lillis, S.; Zhou, H.; Pillay, K.; Henderson, H.; Kress, W.; MÜller, C.R.; Ndondo, A.; Cloke, V.; Cullup, T.; Bertini, E.; Boennemann, C.; Straub, V.; Quinlivan, R.; Dowling, J.J.; Sarraj, S.; Treves, S.; Abbs, S.; Manzur, A.Y.; Sewry, C.A.; Muntoni, F.; Jungbluth, H. (2010). " RYR1 mutations are a common cause of congenital myopathies with central nuclei J.M.W. and S.L. contributed equally to the manuscript. ." Annals of Neurology 68(5): 717-726. <http://hdl.handle.net/2027.42/78229>en_US
dc.identifier.issn0364-5134en_US
dc.identifier.issn1531-8249en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/78229
dc.description.abstractObjective Centronuclear myopathy (CNM) is a rare congenital myopathy characterized by prominence of central nuclei on muscle biopsy. CNM has been associated with mutations in MTM1, DNM2, and BIN1 but many cases remain genetically unresolved. RYR1 encodes the principal sarcoplasmic reticulum calcium release channel and has been implicated in various congenital myopathies. We investigated whether RYR1 mutations cause CNM. Methods We sequenced the entire RYR1 coding sequence in 24 patients with a diagnosis of CNM from South Africa (n = 14) and Europe (n = 10) and identified mutations in 17 patients. The most common genotypes featured compound heterozygosity for RYR1 missense mutations and mutations resulting in reduced protein expression, including intronic splice site and frameshift mutations. Results The high incidence in South African patients (n = 12/14) in conjunction with recurrent RYR1 mutations associated with common haplotypes suggested the presence of founder effects. In addition to central nuclei, prominent histopathological findings included (often multiple) internalized nuclei and type 1 fiber predominance and hypotrophy with relative type 2 hypertrophy. Although cores were not typically seen on oxidative stains, electron microscopy revealed subtle abnormalities in most cases. External ophthalmoplegia, proximal weakness, and bulbar involvement were prominent clinical findings. Interpretation Our findings expand the range of RYR1 -related phenotypes and suggest RYR1 mutations as a common cause of congenital myopathies with central nuclei. Corresponding to recent observations in X-linked CNM, these findings indicate disturbed assembly and/or malfunction of the excitation-contraction machinery as a key mechanism in CNM and related myopathies.ANN NEUROL 2010en_US
dc.format.extent514546 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherNeuroscience, Neurology, and Psychiatryen_US
dc.titleRYR1 mutations are a common cause of congenital myopathies with central nucleien_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pediatrics, University of Michigan Medical Center, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherDepartment of Paediatric Neurology, School of Child and Adolescent Health, University of Cape Town, Red Cross Children's Hospital, Cape Town, South Africaen_US
dc.contributor.affiliationotherDiagnostics Genetics Laboratory, GSTS Pathology, Guy's Hospital, London, UKen_US
dc.contributor.affiliationotherDubowitz Neuromuscular Centre, Institute of Child Health, London, UKen_US
dc.contributor.affiliationotherDepartment of Paediatric Pathology, School of Child and Adolescent Health, University of Cape Town, Red Cross Children's Hospital, Cape Town, South Africaen_US
dc.contributor.affiliationotherMolecular Genetics Department, University of Cape Town, South Africaen_US
dc.contributor.affiliationotherInstitute of Human Genetics, University of Wuerzburg, Biozentrum, Germanyen_US
dc.contributor.affiliationotherInstitute of Human Genetics, University of Wuerzburg, Biozentrum, Germanyen_US
dc.contributor.affiliationotherDepartment of Paediatric Neurology, School of Child and Adolescent Health, University of Cape Town, Red Cross Children's Hospital, Cape Town, South Africaen_US
dc.contributor.affiliationotherDiagnostics Genetics Laboratory, GSTS Pathology, Guy's Hospital, London, UKen_US
dc.contributor.affiliationotherDiagnostics Genetics Laboratory, GSTS Pathology, Guy's Hospital, London, UKen_US
dc.contributor.affiliationotherUnit of Molecular Medicine, Ospedale Bambino GesÙ, Rome, Italyen_US
dc.contributor.affiliationotherDepartment of Paediatric Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USAen_US
dc.contributor.affiliationotherInstitute for Human Genetics, International Centre for Life, University of Newcastle upon Tyne, Newcastle upon Tyne, UKen_US
dc.contributor.affiliationotherCentre for Inherited Neuromuscular Disorders, Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry, UKen_US
dc.contributor.affiliationotherDepartment of Clinical Neuropathology, King's College Hospital, London, UKen_US
dc.contributor.affiliationotherDepartments of Anaesthesia and Research, Basel University Hospital, Basel, Switzerlanden_US
dc.contributor.affiliationotherDiagnostics Genetics Laboratory, GSTS Pathology, Guy's Hospital, London, UKen_US
dc.contributor.affiliationotherDubowitz Neuromuscular Centre, Institute of Child Health, London, UKen_US
dc.contributor.affiliationotherDubowitz Neuromuscular Centre, Institute of Child Health, London, UK ; Centre for Inherited Neuromuscular Disorders, Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry, UKen_US
dc.contributor.affiliationotherDubowitz Neuromuscular Centre, Institute of Child Health, London, UKen_US
dc.contributor.affiliationotherDepartment of Paediatric Neurology, Neuromuscular Service, Evelina Children's Hospital, St Thomas' Hospital, London, UK ; Clinical Neuroscience Division, IOP, King's College, London, UK ; Department of Clinical Neurosciences, IOP, King's College London, and Department of Paediatric Neurology, Evelina Children's Hospital, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UKen_US
dc.identifier.pmid20839240en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/78229/1/22119_ftp.pdf
dc.identifier.doi10.1002/ana.22119en_US
dc.identifier.sourceAnnals of Neurologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.